FABP7 and metabolic dysfunction-associated steatohepatitis: To clarify the role of FABP7 in hepatic macrophages, we established two distinct models: one by inducing hepatic fibrosis via long-term administration of CCl4 and the other by inducing MASH using a high-fat high-cholesterol (HFHC) diet.